Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Understand the key aspects of points and cash back rewards. Equip yourself with knowledge to maximize your benefits.
28,655 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
DeepMind’s 2010 seed and Google’s 2014 buyout sparked debate about exit timing in AI. This report weighs whether the ...
A major fund just disclosed a sizable stake in Tango Therapeutics (TNGX), totaling about $9.5 million. This move shin...
Mercer (MERC) 2026 earnings outlook explained. This analysis breaks down Q1 results, key metrics, and what to expect ...
When Insperity s top executive buys a sizable stake, investors sit up. This article breaks down what insperity stock ...
Medical scares can shake your finances. This guide shows how to rebound with a solid plan: emergency funds, smart ins...
IonQ stunned traders with a sharp rally after reporting stronger-than-expected 2025 results and a robust 2026 revenue...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
Retirees are increasingly building a dividend-driven portfolio that funds two annual cruises while keeping principal ...
A real estate liquidity squeeze is unfolding as investors pull billions from property funds. Could this be the first ...
SpaceX unveiled a century long strategy spanning launches, Starlink, and AI, pushing the company toward a potential $...